Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Helin

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Nature Reviews. Drug Discovery|November 16, 2013
Histone lysine demethylases as targets for anticancer therapyJonas W Højfeldt, Karl Agger, Kristian Helin
Current Opinion in Genetics & Development|January 16, 2002
The role of p53 and pRB in apoptosis and cancerEmma S Hickman, M Cristina Moroni, Kristian Helin
Ugeskrift for Laeger|October 6, 2010
[Basic stem cell biology and cancer]Bo T Porse, Ole W Petersen, Kristian Helin
Nucleic Acids Research|June 30, 2016
Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repressionAliaksandra Radzisheuskaya, Daria Shlyueva, Iris Müller, et al.
The EMBO Journal|November 25, 2003
E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genesLuisa Di Stefano, Michael Rugaard Jensen, Kristian Helin
Journal of Cellular and Molecular Medicine|January 6, 2009
Isolation and characterization of DUSP11, a novel p53 target geneGreta Caprara, Raffaella Zamponi, Marina Melixetian, et al.
Molecular and Cellular Biology|March 16, 2005
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary glandEros Lazzerini Denchi, Claire Attwooll, Diego Pasini, et al.
Trends in Biochemical Sciences|September 15, 2004
E2F target genes: unraveling the biologyAdrian P Bracken, Marco Ciro, Andrea Cocito, et al.
Nature Reviews. Cancer|September 24, 2016
Maintaining cell identity: PRC2-mediated regulation of transcription and cancerItys Comet, Eva M Riising, Benjamin Leblanc, et al.
Current Opinion in Genetics & Development|February 19, 2008
The emerging functions of histone demethylasesKarl Agger, Jesper Christensen, Paul A C Cloos, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Nature Reviews. Drug Discovery|November 16, 2013
Histone lysine demethylases as targets for anticancer therapyJonas W Højfeldt, Karl Agger, Kristian Helin
Current Opinion in Genetics & Development|January 16, 2002
The role of p53 and pRB in apoptosis and cancerEmma S Hickman, M Cristina Moroni, Kristian Helin
Ugeskrift for Laeger|October 6, 2010
[Basic stem cell biology and cancer]Bo T Porse, Ole W Petersen, Kristian Helin
Nucleic Acids Research|June 30, 2016
Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repressionAliaksandra Radzisheuskaya, Daria Shlyueva, Iris Müller, et al.
The EMBO Journal|November 25, 2003
E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genesLuisa Di Stefano, Michael Rugaard Jensen, Kristian Helin
Journal of Cellular and Molecular Medicine|January 6, 2009
Isolation and characterization of DUSP11, a novel p53 target geneGreta Caprara, Raffaella Zamponi, Marina Melixetian, et al.
Molecular and Cellular Biology|March 16, 2005
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary glandEros Lazzerini Denchi, Claire Attwooll, Diego Pasini, et al.
Trends in Biochemical Sciences|September 15, 2004
E2F target genes: unraveling the biologyAdrian P Bracken, Marco Ciro, Andrea Cocito, et al.
Nature Reviews. Cancer|September 24, 2016
Maintaining cell identity: PRC2-mediated regulation of transcription and cancerItys Comet, Eva M Riising, Benjamin Leblanc, et al.
Current Opinion in Genetics & Development|February 19, 2008
The emerging functions of histone demethylasesKarl Agger, Jesper Christensen, Paul A C Cloos, et al.
Pageof 22